Diabetes Victoria

Oct 28, 2024 | trialsjournal.biomedcentral.com | Mary Lou |James A M |Diabetes Victoria

The study will be conducted in Australia, using primarily online methods. Participants will use their own device(s) (i.e. laptop, desktop, smartphone, and/or tablet computer) from a physical location of their choice. Platform O, a Deakin University owned and developed e-research platform, will be used to host the online intervention and automate data collection and email reminder systems.

May 23, 2023 | trialsjournal.biomedcentral.com | Mary Lou |van Bruggen |Diabetes Victoria |Le Gautier

DesignThis study uses a hybrid type I effectiveness-implementation trial design [26] to test the effectiveness of LISTEN in a two-arm pragmatic, individual-level randomised controlled trial (RCT). We will simultaneously gather information on any barriers to, and facilitators of, implementation [26]. LISTEN (intervention) will be compared to usual care (comparison group), in terms of its impact on diabetes distress at 8 weeks (T1) and 6 months (T2) post-randomisation.

Mar 1, 2023 | frontiersin.org | Diabetes Victoria

Elizabeth Holmes-Truscott1, 2*, Shaira Baptista1, 2, Mathew Ling3, Elif I. Ekinci4, Eileen Collins2, John Furler4, Virginia Hagger1, Jo-Anne Manski-Nankervis4, Caroline Wells5 and Jane Speight1, 2 1Deakin University, Australia 2Diabetes Victoria, Australia 3Neami National, Australia 4The University of Melbourne, Australia 5Diabetes Australia, Australia The final, formatted version of the article will be published soon.